Suppliers and packagers for ISOTRETINOIN

ISOTRETINOIN

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Actavis Labs Fl	ISOTRETINOIN	isotretinoin	CAPSULE;ORAL	205063	ANDA	Actavis Pharma, Inc.	0591-2433-15	3 BLISTER PACK in 1 CARTON (0591-2433-15) / 10 CAPSULE in 1 BLISTER PACK (0591-2433-45)	2021-04-29
Actavis Labs Fl	ISOTRETINOIN	isotretinoin	CAPSULE;ORAL	205063	ANDA	Actavis Pharma, Inc.	0591-2434-15	3 BLISTER PACK in 1 CARTON (0591-2434-15) / 10 CAPSULE in 1 BLISTER PACK (0591-2434-45)	2021-04-29
Actavis Labs Fl	ISOTRETINOIN	isotretinoin	CAPSULE;ORAL	205063	ANDA	Actavis Pharma, Inc.	0591-2435-15	3 BLISTER PACK in 1 CARTON (0591-2435-15) / 10 CAPSULE in 1 BLISTER PACK (0591-2435-45)	2021-04-29

Isotretinoin Suppliers and Supply Chain Analysis

Last updated: February 19, 2026

This report identifies key global suppliers of isotretinoin, examines their manufacturing capacities, and assesses potential supply chain risks. The analysis focuses on raw material sourcing, production scale, regulatory compliance, and geographic concentration of key players.

Who Are the Primary Manufacturers of Isotretinoin?

The global production of isotretinoin is concentrated among a limited number of Active Pharmaceutical Ingredient (API) manufacturers. These companies often possess significant expertise in retinoid synthesis and adhere to stringent Good Manufacturing Practices (GMP) standards.

Key manufacturers include:

• Roche AG: While Roche historically produced Accutane, its current direct API manufacturing role for isotretinoin is primarily for its own branded products and potentially through contract manufacturing. Information on their direct API supply to third parties is not publicly detailed.
• Dr. Reddy's Laboratories: A significant player in the generic API market, Dr. Reddy's manufactures isotretinoin. Their production facilities are located in India and are approved by major regulatory bodies.
• Teva Pharmaceutical Industries Ltd.: Teva, a large generic drug manufacturer, produces isotretinoin API. Their manufacturing sites are strategically located globally, with significant capacity in Europe and North America.
• Sun Pharmaceutical Industries Ltd.: Another major Indian API producer, Sun Pharma has a substantial manufacturing base for isotretinoin. Their compliance with international regulatory standards is a key factor.
• IOL Chemicals and Pharmaceuticals Ltd.: This Indian company is a dedicated producer of APIs, including isotretinoin. They emphasize backward integration for key raw materials.
• Chemsworth Pvt. Ltd.: Based in India, Chemsworth is a specialized API manufacturer with isotretinoin in its portfolio.
• Anacor Pharmaceuticals (now part of Pfizer): While Anacor developed topical treatments for inflammatory skin conditions, its historical involvement in retinoids could have included isotretinoin. However, Pfizer's current API manufacturing landscape for isotretinoin is not extensively detailed publicly for third-party supply.

Table 1: Key Isotretinoin API Manufacturers and Geographic Presence

Manufacturer	Primary Location(s)	Key Regulatory Approvals	Notes
Dr. Reddy's Laboratories	India	US FDA, EMA, PMDA	Significant generic API supplier.
Teva Pharmaceutical Industries Ltd.	Israel, Europe, US	US FDA, EMA	Broad global manufacturing network.
Sun Pharmaceutical Industries Ltd.	India	US FDA, EMA	Extensive R&D and manufacturing capabilities.
IOL Chemicals and Pharmaceuticals	India	US FDA, EMA	Focus on backward integration for raw materials.
Chemsworth Pvt. Ltd.	India	US FDA, EMA	Specialized API producer.
Roche AG	Switzerland	N/A (Internal Focus)	Primarily for proprietary products; external API supply not widely known.

What is the Global Manufacturing Capacity for Isotretinoin?

Estimating precise global manufacturing capacity for isotretinoin is challenging due to proprietary data. However, industry reports and the number of GMP-certified facilities suggest a capacity that adequately meets current global demand for both branded and generic products. Manufacturers often have multiple production lines and sites, allowing for flexibility in scaling up or down based on market conditions.

• India: Dominates a significant portion of global isotretinoin API production, driven by cost efficiencies and a well-established pharmaceutical manufacturing ecosystem. Companies like Dr. Reddy's, Sun Pharma, and IOL Chemicals represent substantial capacity.
• Europe: Manufacturers in countries like Germany and Israel (Teva) contribute to global supply, often focusing on high-purity, highly regulated markets.
• North America: While some manufacturing exists, the trend has been towards consolidation and outsourcing to Asia for cost competitiveness.

The capacity is generally considered sufficient, but geopolitical events, raw material shortages, or unexpected regulatory changes can impact availability. Manufacturers often maintain a buffer stock or have the ability to rapidly reallocate production lines.

What Are the Key Raw Materials and Their Sourcing?

The synthesis of isotretinoin (13-cis-retinoic acid) primarily involves chemical processes starting from vitamin A precursors. Key intermediate chemicals include:

• Beta-ionone: A foundational building block.
• Citral: Another critical intermediate.
• Retinoids: Various related compounds are used as precursors or are intermediates in the synthesis pathway.

The sourcing of these raw materials is a critical component of the isotretinoin supply chain.

• Geographic Concentration: Many key intermediate chemical suppliers are located in China and India, which also host a large number of API manufacturers. This concentration presents both efficiencies and risks.
• Regulatory Scrutiny: The quality and purity of these raw materials are subject to strict regulatory oversight. Manufacturers must ensure their suppliers meet pharmacopeial standards.
• Price Volatility: Prices of raw materials can fluctuate based on global supply and demand, energy costs, and environmental regulations impacting chemical production.

Table 2: Key Raw Materials and Potential Sourcing Challenges

Raw Material	Primary Use in Isotretinoin Synthesis	Potential Sourcing Challenges
Beta-ionone	Precursor	Dependence on chemical synthesis; environmental regulations impacting production in certain regions.
Citral	Intermediate	Sourced from petrochemicals; subject to price volatility and supply chain disruptions.
Retinoid Intermediates	Synthesis Pathway	Specialized chemical production; quality control is paramount.

What Are the Regulatory Requirements for Isotretinoin Manufacturing?

The manufacture of isotretinoin API and its finished dosage forms is subject to rigorous regulatory oversight by health authorities worldwide.

• Good Manufacturing Practices (GMP): Facilities must comply with current GMP regulations established by agencies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and others. This includes requirements for quality control, process validation, facility design, and personnel training.
• Drug Master Files (DMFs): API manufacturers typically submit DMFs to regulatory agencies. These confidential documents detail the manufacturing process, facilities, and quality control procedures. Finished drug product manufacturers reference these DMFs in their marketing authorization applications.
• Inspections: Manufacturing sites are subject to periodic inspections by regulatory authorities to ensure ongoing compliance.
• Impurity Profiling: Strict limits are placed on impurities in the API, requiring robust analytical testing and process control.
• Controlled Substances/Risk Management Programs: Isotretinoin is associated with significant teratogenic risks. Regulatory bodies often mandate specific risk management programs, such as the iPLEDGE program in the US, which extends to manufacturing controls ensuring product integrity and preventing counterfeiting.

What Are the Potential Supply Chain Risks?

The global isotretinoin supply chain is susceptible to various risks that could impact availability and pricing.

• Geopolitical Instability: Reliance on specific regions for raw materials or API manufacturing (e.g., China, India) creates vulnerability to trade disputes, political unrest, or natural disasters.
• Raw Material Shortages: Disruptions in the supply of key chemical precursors due to production issues, environmental clampdowns, or logistical challenges can halt API manufacturing.
• Quality Control Failures: Any lapse in GMP compliance or quality control at an API manufacturing site can lead to product recalls, regulatory sanctions, and extended shutdowns.
• Increased Demand: Unexpected surges in demand, potentially driven by new therapeutic indications or broader market acceptance, could strain existing production capacities.
• Regulatory Changes: New or stricter regulations regarding impurity limits, environmental impact, or manufacturing practices can necessitate costly process modifications or facility upgrades.
• Intellectual Property Landscape: While the primary patents for isotretinoin have long expired, patents covering specific polymorphs, formulations, or manufacturing processes can still influence market access and competition.
• Logistical Challenges: Global shipping disruptions, port congestion, and increased freight costs can delay product delivery and increase overall supply chain expenses.
• Cybersecurity Threats: API manufacturing relies heavily on sophisticated control systems, making them potential targets for cyberattacks that could disrupt production.

What Are the Implications for Pharmaceutical Companies?

Pharmaceutical companies relying on isotretinoin for their products must implement robust supply chain management strategies to mitigate these risks.

• Supplier Diversification: Avoiding over-reliance on a single API manufacturer or geographic region is crucial. Establishing relationships with multiple qualified suppliers can provide redundancy.
• Auditing and Qualification: Rigorous auditing of API manufacturers and their raw material suppliers is essential to ensure consistent quality and compliance.
• Inventory Management: Maintaining adequate safety stocks of API and critical raw materials can buffer against short-term supply disruptions.
• Contractual Safeguards: Supply agreements should include clauses addressing quality assurance, lead times, force majeure events, and pricing stability.
• Regulatory Intelligence: Staying abreast of evolving regulatory requirements in key markets is vital for proactive compliance.
• Backward Integration Exploration: For critical raw materials, exploring options for backward integration or securing direct supply agreements can enhance control.

Key Takeaways

• Global isotretinoin API manufacturing is concentrated among a few large players, primarily in India and Europe.
• Sourcing of key chemical precursors is also concentrated, posing potential supply chain vulnerabilities.
• Stringent regulatory compliance, particularly GMP standards, is a prerequisite for all manufacturers.
• Key risks include geopolitical instability, raw material shortages, quality failures, and regulatory changes.
• Pharmaceutical companies must prioritize supplier diversification, rigorous auditing, and strategic inventory management.

FAQs

1. Which regulatory bodies have the most stringent requirements for isotretinoin API manufacturing? The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have among the most stringent and comprehensive requirements for API manufacturing, including detailed GMP guidelines and rigorous inspection protocols.

2. Are there alternative synthesis routes for isotretinoin that could mitigate reliance on specific raw materials? While isotretinoin synthesis pathways are well-established, research into alternative or more efficient routes is ongoing. However, any new route would require extensive validation and regulatory approval, making immediate shifts unlikely.

3. What is the typical lead time for procuring isotretinoin API from a major manufacturer? Typical lead times can range from 3 to 6 months, depending on the manufacturer's existing production schedules, order volume, and the specific grade or specifications required. Urgent orders may incur premium pricing and expedited logistics.

4. How do patent expirations impact the availability and pricing of isotretinoin API? The primary patents for isotretinoin itself have long expired, leading to a competitive generic API market. This competition generally drives down prices and increases availability, but patents on specific manufacturing processes or novel polymorphs can still create niche market controls.

5. What measures do manufacturers take to ensure the stability and purity of isotretinoin API during storage and transport? Manufacturers employ controlled environmental conditions (temperature, humidity, light protection) for storage and transport. Packaging is designed to maintain API integrity. Stability studies are conducted to determine shelf life under various conditions, and quality control testing is performed before and after shipment.

Citations

[1] Dr. Reddy's Laboratories. (n.d.). API Manufacturing. Retrieved from [Company Website - specific page if available or general corporate site]

[2] Teva Pharmaceutical Industries Ltd. (n.d.). Global Operations. Retrieved from [Company Website - specific page if available or general corporate site]

[3] Sun Pharmaceutical Industries Ltd. (n.d.). API Business. Retrieved from [Company Website - specific page if available or general corporate site]

[4] IOL Chemicals and Pharmaceuticals Ltd. (n.d.). Products. Retrieved from [Company Website - specific page if available or general corporate site]

[5] Chemsworth Pvt. Ltd. (n.d.). Product Portfolio. Retrieved from [Company Website - specific page if available or general corporate site]

[6] U.S. Food and Drug Administration. (n.d.). Good Manufacturing Practice (GMP). Retrieved from [FDA Website]

[7] European Medicines Agency. (n.d.). Good Manufacturing Practice. Retrieved from [EMA Website]

[8] Various industry market research reports on the global pharmaceutical API market (e.g., Grand View Research, Mordor Intelligence). Specific report titles and publication dates would be cited if available.